Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.
M MatignonJ-D LelièvreA LahianiK AbbassiD DesvauxA DialloM-N PeraldiA-M TaburetJ SaillardC DelaugerreD CostagliolaLambert AssoumouP Grimbertnull nullPublished in: HIV medicine (2019)
Acute rejection rates were low after kidney transplantation in PLHIV treated with a raltegravir-based regimen. However, PLHIV have poorer access to transplantation than HIV-uninfected individuals after registration on the waiting list.
Keyphrases
- hiv infected
- kidney transplantation
- antiretroviral therapy
- hiv infected patients
- liver failure
- human immunodeficiency virus
- respiratory failure
- hiv positive
- hiv aids
- drug induced
- aortic dissection
- clinical trial
- hepatitis b virus
- risk factors
- newly diagnosed
- study protocol
- mesenchymal stem cells
- extracorporeal membrane oxygenation
- hiv testing
- men who have sex with men
- bone marrow
- mechanical ventilation